Supplementary Figure S3 from Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial
Open Access
- 15 July 2024
- other
- Published by American Association for Cancer Research (AACR)